Predictive Value of Computed Tomography Characteristics for Nivolumab Response in Pretreated Non-Small Cell Lung Cancer

被引：0

作者：

Imai, H. ^{[1
]}

Minemura, H. ^{[2
]}

Moriya, H. ^{[3
]}

Sugiyama, T. ^{[4
]}

Yamada, Y. ^{[5
]}

Higuchi, M. ^{[6
]}

Kaira, K. ^{[7
]}

Ozaki, Y. ^{[8
]}

Kanazawa, K. ^{[2
]}

Yokouchi, H. ^{[9
]}

Kasai, T. ^{[4
]}

Kaburagi, T. ^{[5
]}

Suzuki, H. ^{[8
]}

Minato, K. ^{[1
]}

Shibata, Y. ^{[2
]}

机构：

[1] Gunma Prefectural Canc Ctr, Div Resp Med, Ota, Gunma, Japan

[2] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan

[3] Ohara Gen Hosp, Diagnost Imaging Ctr, Fukushima, Japan

[4] Tochigi Canc Ctr, Div Thorac Oncol, Utsunomiya, Tochigi, Japan

[5] Ibaraki Prefctural Cent Hosp & Canc Ctr, Resp Med, Ibaraki, Japan

[6] Fukushima Med Univ, Dept Surg, Aizu Med Ctr, Fukushima, Japan

[7] Saitama Med Univ, Dept Resp Med, Int Med Ctr, Saitama, Japan

[8] Fukushima Med Univ, Sch Med, Dept Chest Surg, Fukushima, Japan

[9] Natl Hosp Org Hokkaido Canc Ctr, Dept Resp Med, Sapporo, Hokkaido, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

non-small cell lung cancer; immune check point inhibitor; Morphologic characteristics;

D O I：

10.1016/j.jtho.2018.08.1603

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-43

引用

页码：S883 / S884

页数：2

共 50 条

[1] Predictive Immunologic Markers of Response to Nivolumab in Non-Small Cell Lung Cancer
Genova, Carlo
Carrega, Paolo
Distefano, Roberta
Ottonello, Selene
Pietra, Gabriella
Cossu, Irene
Rijavec, Erika
Biello, Federica
Rossi, Giovanni
Barletta, Giulia
Dal Bello, Maria Giovanna
Alama, Angela
Coco, Simona
Vanni, Irene
Maggioni, Claudia
Merlo, Franco
Mingari, Maria Cristina
Grosse, Francesco
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1320 - S1321
[2] Nivolumab in pretreated non-small cell lung cancer: continuing the immunolution
Salati, Massimiliano
Baldessari, Cinzia
Cerbelli, Bruna
Botticelli, Andrea
TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S91 - S94
[3] Carcinoembryonic Antigen as a Predictive Biomarker of Response to Nivolumab in Non-small Cell Lung Cancer
Kataoka, Yuki
Hirano, Katsuya
Narabayashi, Tomoko
Hara, Satoshi
Fujimoto, Daichi
Tanaka, Tae
Ebi, Noriyuki
Tomii, Keisuke
Yoshioka, Hiroshige
ANTICANCER RESEARCH, 2018, 38 (01) : 559 - 563
[4] Predictive clinical parameters for the response of nivolumab in pretreated advanced non-small-cell lung cancer
Oya, Yuko
Yoshida, Tatsuya
Kuroda, Hiroaki
Mikubo, Masashi
Kondo, Chiaki
Shimizu, Junichi
Horio, Yoshitsugu
Sakao, Yukinori
Hida, Toyoaki
Yatabe, Yasushi
ONCOTARGET, 2017, 8 (61) : 103117 - 103128
[5] Computed tomography texture analysis of response to second-line nivolumab in metastatic non-small cell lung cancer
Ladwa, Rahul
Roberts, Kate E.
O'Leary, Connor
Maggacis, Nicole
O'Byrne, Kenneth J.
Miles, Kenneth
LUNG CANCER MANAGEMENT, 2020, 9 (03)
[6] Computed tomography imaging of non-small cell lung cancer
Chassagnon, G.
Bennani, S.
Revel, M. P.
CANCER RADIOTHERAPIE, 2016, 20 (6-7): : 694 - 698
[7] Predicting recurrence of non-small cell lung cancer based on mean computed tomography value
Masaya Tamura
Isao Matsumoto
Yusuke Tanaka
Daisuke Saito
Shuhei Yoshida
Munehisa Takata
Journal of Cardiothoracic Surgery, 16
[8] Predicting recurrence of non-small cell lung cancer based on mean computed tomography value
Tamura, Masaya
Matsumoto, Isao
Tanaka, Yusuke
Saito, Daisuke
Yoshida, Shuhei
Takata, Munehisa
JOURNAL OF CARDIOTHORACIC SURGERY, 2021, 16 (01)
[9] Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study
Kataoka, Y.
Hirano, K.
Narabayashi, T.
Hara, S.
Fujimoto, D.
Tanaka, T.
Ebi, N.
Tomii, K.
Yoshioka, H.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1995 - S1995
[10] The value of contrast-enhanced computed tomography in evaluating patient response to Icotinib for non-small cell lung cancer
Yu, Jinping
Liu, Haixia
Chen, Hong
Ren, Shuhua
BIOMEDICAL RESEARCH-INDIA, 2016, 27 (03): : 905 - 911

← 1 2 3 4 5 →